STOCK TITAN

[15-12G] Generation Bio Co. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
15-12G

Rhea-AI Filing Summary

Analyzing...

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 001-39319

Generation Bio Co.

(Exact name of registrant as specified in its charter)

2200 Powell Street, Suite 310

Emeryville, California 94608

(510) 204-7200

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, par value $0.0001 per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(l)

Rule 12g-4(a)(2)

Rule 12h-3(b)(l)(i)

Rule 12h-3(b)(l)(ii)

Rule 15d-6

Rule 15d-22(b)

Approximate number of holders of record as of the certification or notice date: one (1) holder.

Pursuant to the requirements of the Securities Exchange Act of 1934, Generation Bio Co. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Generation Bio Co.

 

 

 

By:

/s/ Owen Hughes

 

Name:

Owen Hughes

 

Title:

President, Treasurer and Secretary

 

 

Date: February 19, 2026

 


Generation Bio Co.

NASDAQ:GBIO

GBIO Rankings

GBIO Latest News

GBIO Latest SEC Filings

GBIO Stock Data

35.98M
5.78M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE